<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">NS</journal-id><journal-title-group><journal-title>Nursing Science</journal-title></journal-title-group><issn pub-type="epub">2168-5657</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/NS.2020.96068</article-id><article-id pub-id-type="publisher-id">NS-39437</article-id><article-categories><subj-group subj-group-type="heading"><subject>NS20200600000_81725766.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  CO
  <sub>2</sub>点阵激光联合复方倍他米松注射液外敷治疗白癜风的疗效观察
   Observation on Viti-ligo Patients Treated by the Fractional Carbon Dioxide Laser with Topical Betamethasone
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>陈</surname><given-names>玉杰</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>孟</surname><given-names>祖东</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>雪</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>湖北医药学院附属人民医院皮肤科，湖北 十堰</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>02</day><month>12</month><year>2020</year></pub-date><volume>09</volume><issue>06</issue><fpage>416</fpage><lpage>419</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   目的：观察CO<sub>2</sub>点阵激光联合复方倍他米松注射液外敷治疗白癜风的临床疗效。方法：将80例随机分为研究组(40例)和对照组(40例)。研究组给予CO<sub>2</sub>点阵激光联合倍他米松注射液外敷治疗；对照组仅给予CO<sub>2</sub>点阵激光治疗，间隔15天做一次，均治疗6次(即3个月)后判断疗效。结果：研究组总有效率85%；对照组52.5%。两组治疗效果比较，χ&#178; = 9.101，P = 0.0017 &lt; 0.05，有显著性差异。结论：CO<sub>2</sub>点阵激光联合复方倍他米松注射液治疗白癜风患者，疗效显著，可有效提高复色率，降低复发率，安全性高。  Objective: The aim of the study is to observe the effect of the fractional carbon dioxide Laser combined with topical betamethasone on patients with vitiligo. Methods: 80 vitiligo patients were randomly divided into study group and control group. The study group were given the therapy of CO<sub>2</sub> Fractional Laser combined with topical betamethasone, while the control group only treated by CO<sub>2</sub> Fractional Laser therapy, once every 15 days. Both of the periods of treatment were 3 months. Results: The effective rate of study group was 85%, while the control group was 52.5%. There was a significant difference compared with the efficiency of the two groups (χ&#178; = 9.101, P = 0.0017 &lt; 0.05). Conclusion: The treatment of the fractional carbon dioxide laser with topical betamethasone in patients of vitiligo is safe and effective. 
 
</p></abstract><kwd-group><kwd>白癜风，CO<sub>2</sub>点阵激光，倍他米松注射液,  Vitiligo</kwd><kwd> Fractional Carbon Dioxide Laser</kwd><kwd> Betame-thasone</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>目的：观察CO<sub>2</sub>点阵激光联合复方倍他米松注射液外敷治疗白癜风的临床疗效。方法：将80例随机分为研究组(40例)和对照组(40例)。研究组给予CO<sub>2</sub>点阵激光联合倍他米松注射液外敷治疗；对照组仅给予CO<sub>2</sub>点阵激光治疗，间隔15天做一次，均治疗6次(即3个月)后判断疗效。结果：研究组总有效率85%；对照组52.5%。两组治疗效果比较，χ&#178; = 9.101，P = 0.0017 &lt; 0.05，有显著性差异。结论：CO<sub>2</sub>点阵激光联合复方倍他米松注射液治疗白癜风患者，疗效显著，可有效提高复色率，降低复发率，安全性高。</p></sec><sec id="s2"><title>关键词</title><p>白癜风，CO<sub>2</sub>点阵激光，倍他米松注射液</p></sec><sec id="s3"><title>Observation on Vitiligo Patients Treated by the Fractional Carbon Dioxide Laser with Topical Betamethasone</title><p>Yujie Chen, Zudong Meng, Xue Wang<sup>*</sup></p><p>Department of Dermatology, Renmin Hospital, Hubei University of Medicine, Shiyan Hubei</p><p><img src="//html.hanspub.org/file/10-2250571x4_hanspub.png" /></p><p>Received: Nov. 23<sup>rd</sup>, 2020; accepted: Dec. 21<sup>st</sup>, 2020; published: Dec. 28<sup>th</sup>, 2020</p><p><img src="//html.hanspub.org/file/10-2250571x5_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Objective: The aim of the study is to observe the effect of the fractional carbon dioxide Laser combined with topical betamethasone on patients with vitiligo. Methods: 80 vitiligo patients were randomly divided into study group and control group. The study group were given the therapy of CO<sub>2</sub> Fractional Laser combined with topical betamethasone, while the control group only treated by CO<sub>2</sub> Fractional Laser therapy, once every 15 days. Both of the periods of treatment were 3 months. Results: The effective rate of study group was 85%, while the control group was 52.5%. There was a significant difference compared with the efficiency of the two groups (χ&#178; = 9.101, P = 0.0017 &lt; 0.05). Conclusion: The treatment of the fractional carbon dioxide laser with topical betamethasone in patients of vitiligo is safe and effective.</p><p>Keywords:Vitiligo, Fractional Carbon Dioxide Laser, Betamethasone</p><disp-formula id="hanspub.39437-formula2"><graphic xlink:href="//html.hanspub.org/file/10-2250571x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2020 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/10-2250571x8_hanspub.png" /> <img src="//html.hanspub.org/file/10-2250571x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>白癜风为临床常见的一种色素障碍性皮肤病，目前在我国发生率约为0.56%。本病无特定好发部位，常见于四肢、手背、颜面、背部等，虽然该疾病并不影响患者的身体健康，但是会增加患者的精神压力，而精神心理因素又是诱发白癜风发病的一个重要诱因，进一步影响患者的工作、生活、学习等 [<xref ref-type="bibr" rid="hanspub.39437-ref1">1</xref>] [<xref ref-type="bibr" rid="hanspub.39437-ref2">2</xref>]。点阵激光是近年来兴起的治疗白癜风的手段，可通过多种作用机制促进白癜风皮疹复色 [<xref ref-type="bibr" rid="hanspub.39437-ref3">3</xref>]。笔者收集科室门诊2018年1月~2019年12月采用CO<sub>2</sub>点阵激光联合倍他米松注射液外敷治疗的白癜风病例，进行回顾性分析，现报道如下。</p></sec><sec id="s6"><title>2. 资料与方法</title><sec id="s6_1"><title>2.1. 一般资料</title><p>收集2018年1月至2019年12月在我院皮肤科门诊就医的稳定期白癜风患者80例，随机分为两组。研究组40例，其中男19例，女21例；年龄8~55岁，平均22岁；病程2个月~3年，平均2.7年，发病部位面部15例，躯干12例、四肢13例。对照组40例，其中男22例，女18例；年龄10~58岁，平均24岁；病程3个月~5年，平均3.4年，发病部位面部16例，躯干14例、四肢10例。两组一般资料比较差异无统计学意义(P &gt; 0.05)，具有可比性。</p></sec><sec id="s6_2"><title>2.2. 入选标准</title><p>1) 所有病例均符合《皮肤性病学》中白癜风诊断标准 [<xref ref-type="bibr" rid="hanspub.39437-ref4">4</xref>]，皮损主要分布于面部、躯干及四肢，且为单发性，单发或聚集性白斑，大小不一，局限于某一部位；患病后3个月内未接受其他系统治疗。2) 患者及家属依从性好，并自愿签署知情同意书。</p></sec><sec id="s6_3"><title>2.3. 排除标准</title><p>1) 备孕、妊娠或哺乳期女性白癜风患者；2) 患有严重心、肝、肾等脏器疾病者；3) 合并免疫缺陷疾病者；4) 患处存在疱疹病毒等感染或湿疹等过敏性疾病者；5) 瘢痕体质；6) 近2个月接受白癜风治疗者；7) 既往存在色素沉着异常史者；8) 治疗依从性较差者。9) 对利多卡因过敏者。</p></sec><sec id="s6_4"><title>2.4. 方法</title><p>两组患者均在治疗前给予复方利多卡因膏外涂后保鲜膜封包，40分钟后清洗复方利多卡因膏，碘伏消毒施术部位后进行CO<sub>2</sub>点阵激光(北京赫尔兹医疗科技有限责任公司，型号HL-1R)治疗，能量根据皮损颜色情况进行调整，能量范围20~30 mJ/cm<sup>2</sup>，波长10,600 nm，间距4~6，覆盖率5%，应用点阵模式，在皮肤上形成点阵形微小孔道，治疗间隔时间15 d，持续治疗6次为1个疗程。研究组在对照组基础上加用复方倍他米松注射液(杭州默沙制药有限公司，国药准字J20140160)外敷，用0.9%生理盐水1:1将稀释复方倍他米松注射液后用无菌棉片湿敷于白癜风皮损处，湿度以不滴水为宜，并用保鲜膜封包以利药物的吸收，湿敷时间30分钟。</p></sec><sec id="s6_5"><title>2.5. 观察指标</title><p>对两组治疗效果进行比较，疗效评价标准 [<xref ref-type="bibr" rid="hanspub.39437-ref5">5</xref>]：痊愈：白斑全部消退，皮肤恢复正常颜色；显效：疗程结束后患者皮疹颜色变红，复色面积&gt;75%；有效：疗程结束后患者皮疹颜色变红，复色面积&gt;50%；无效：治疗后患者皮疹颜色、范围均无明显改善。总有效率 = (痊愈 + 显效)/例数。同时对两组治疗后不良反应进行观察。</p></sec><sec id="s6_6"><title>2.6. 统计学处理</title><p>采用SPSS13.0统计软件进行分析，应用χ&#178;检验，P &lt; 0.05为差异有统计学意义。</p></sec></sec><sec id="s7"><title>3. 治疗结果</title><p>临床疗效 研究组40例，痊愈14例，显效20例，有效5例，无效1例，总有效率85%；对照组40例，痊愈10例，显效18例，有效9例，无效1例，总有效率52.5%。两组治疗效果比较χ&#178; = 9.101，Ｐ= 0.0017 &lt; 0.05差异有显著性，见表1。</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> The efficacy comparison between two groups of patient</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >组别</th><th align="center" valign="middle" >例数</th><th align="center" valign="middle" >痊愈</th><th align="center" valign="middle" >显效</th><th align="center" valign="middle" >有效</th><th align="center" valign="middle" >无效</th><th align="center" valign="middle" >总有效率 (%)</th></tr></thead><tr><td align="center" valign="middle" >研究组</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >85</td></tr><tr><td align="center" valign="middle" >对照组</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >52.5</td></tr></tbody></table></table-wrap><p>表1. 两组白癜风患者疗效比较(例%)</p><p>注：与对照组比较，χ&#178; = 9.101，P = 0.0017 &lt; 0.05。</p><p>不良反应：两组患者均有术后局部创面红肿，灼痛以及灼热感，经过冷敷后症状即可改善。其他无明显不良反应，两组患者对治疗均耐受良好，并且都能坚持一个疗程的治疗。</p></sec><sec id="s8"><title>4. 护理</title><p>1) 治疗前护理。做好常规接诊工作，拍照留档，做好姓名、性别、年龄、联系方式等一般资料的登记。告知患者点阵激光治疗的原理、治疗过程中的配合以及治疗后的注意事项等。及时了解患者心理需求并给予开导，耐心解答患者的疑问，告知患者预期的效果，让患者放松心情，消除对激光治疗的紧张情绪。嘱咐患者术后7天内激光创面保持清洁干燥。</p><p>2) 治疗中护理。施术部位给予活力碘消毒后用生理盐水清洗局部。在治疗过程中给予心理护理，放轻音乐、讲故事等方法转移患者注意力，每个过程配合施术者与患者进行沟通，及时解决患者的需求。操作过程中，动作轻柔，言语和蔼，以取得患者信任 [<xref ref-type="bibr" rid="hanspub.39437-ref6">6</xref>]。</p><p>3) 治疗后护理。治疗结束后，施术部位立即冰袋冷敷30 min (减轻余热损伤 )，在冬天进行的手术要告诉患者注意保暖，避免受凉。告知患者术后早期存在局部的疼痛感及烧灼感，居家冷敷可缓解。指导患者一周内不沾生水，7 d内施术部位一般会结痂，避免用手撕脱痂皮，使其自动脱落；及时随访，指导患者15天后复诊。</p></sec><sec id="s9"><title>5. 讨论</title><p>白癜风的临床表现为皮肤的色素脱失，直接影响患者容貌及躯体肤色美观，给患者带来心理负担及负面情绪，影响患者工作、生活、学习。药物治疗和物理治疗等无创治疗是目前主要的治疗方法 [<xref ref-type="bibr" rid="hanspub.39437-ref7">7</xref>] [<xref ref-type="bibr" rid="hanspub.39437-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.39437-ref9">9</xref>]。复方倍他米松为倍他米松和二丙酸倍他米松的复方制剂，具有较强的抗炎、抗过敏效果，可快速被吸收，持续产生作用，进而长时间控制患者临床症状，近年来逐渐广泛应用于白癜风治疗中 [<xref ref-type="bibr" rid="hanspub.39437-ref10">10</xref>]。CO<sub>2</sub>点阵激光主要针对表皮及真皮浅层，对其进行汽化和剥脱，不仅可刺激黑素增殖与迁移，还可促进外用药物穿透到角质层深层，增强其疗效 [<xref ref-type="bibr" rid="hanspub.39437-ref11">11</xref>]。CO<sub>2</sub>点阵激光与复方倍他米松注射液的联合治疗，具有良好的协同作用，比单独使用CO<sub>2</sub>点阵激光治疗具有更满意的疗效。同时给予患者心理护理、健康宣教等干预，使患者了解疾病和治疗的相关知识，让患者明确在治疗过程中的注意事项，积极配合治疗，增强患者的依从性及自信心，提高治疗效果，提升患者的满意度，从而提高患者的生活质量。本研究的局限性在于样本量仍偏小，笔者将继续增加样本量进一步验证本实验的结果。</p><p>综上所述，CO<sub>2</sub>点阵激光联合复方倍他米松注射液外敷治疗白癜风患者，疗效显著，可有效提高复色率，降低复发率，安全性好，患者满意度高，值得临床推广应用。</p></sec><sec id="s10"><title>基金项目</title><p>湖北省卫生计生科研项目，基金号WJ2019F048。</p></sec><sec id="s11"><title>文章引用</title><p>陈玉杰,孟祖东,王 雪. CO<sub>2</sub>点阵激光联合复方倍他米松注射液外敷治疗白癜风的疗效观察 Observation on Viti-ligo Patients Treated by the Fractional Carbon Dioxide Laser with Topical Betamethasone[J]. 护理学, 2020, 09(06): 416-419. https://doi.org/10.12677/NS.2020.96068</p></sec><sec id="s12"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.39437-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">坚哲, 李凯, 刘邦民, 等. 白癜风10000例临床特征及治疗效果分析[J]. 中国美容医学, 2012, 21(11): 1577-1580.</mixed-citation></ref><ref id="hanspub.39437-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">陈燕, 钟桂书. CO2点阵激光联合得宝松治疗白癜风疗效观察[J]. 中国美容医学, 2015, 24(12): 56-58.</mixed-citation></ref><ref id="hanspub.39437-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">梅册芳, 温景, 张少茹, 等. CO2点阵激光联合丙酸氟替卡松乳膏治疗稳定期白癜风的疗效观察[J]. 中国医疗美容, 2019, 9(4): 59-60.</mixed-citation></ref><ref id="hanspub.39437-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">张学军. 皮肤性病学[M]. 第8版. 北京: 人民卫生出版社, 2013: 185-187.</mixed-citation></ref><ref id="hanspub.39437-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">李静波, 闵仲生. 白癜风丸联合308 nm准分子光治疗白癜风疗效观[J]. 中国美容医学, 2016, 25(7): 95-96.</mixed-citation></ref><ref id="hanspub.39437-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">王艳, 王芳芳, 熊玮, 等. 二氧化碳点阵激光治疗前后的护理[J]. 中外医学研究, 2017, 15(21): 77-78.</mixed-citation></ref><ref id="hanspub.39437-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">刘玮, 牟宽厚, 韩丹, 等. 白癜风与老年性白斑临床特征和皮损超微结构比较[J]. 中国皮肤性病学杂志, 2016, 30(8): 793-795.</mixed-citation></ref><ref id="hanspub.39437-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Moulinas, C., Dollfus, H. and Lipsker, D. (2015) Leueoderma in Children: Review of the Literature. Annales de Dermatologie et de Vénéréologie, 142, 399.</mixed-citation></ref><ref id="hanspub.39437-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">李庆娟, 王丽, 王莹, 等. 308 nm准分子光联合CO2点阵激光治疗稳定期白癜风的疗效观察[J]. 中医临床研究, 2018, 10(33): 65-66.</mixed-citation></ref><ref id="hanspub.39437-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">董炜, 张慧, 王彦. 1565 nm非剥脱点阵激光联合糖皮质激素治疗增生性瘢痕疗效观察[J]. 农垦医学, 2018, 40(3): 19-22.</mixed-citation></ref><ref id="hanspub.39437-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">高涛, 武瑞霞, 等. 超脉冲CO2点阵激光及高能紫外线联合他克莫司治疗不同类型白癜风皮损的疗效及相关影响因素分析[J]. 中国美容医学, 2019, 28(12): 59-61.</mixed-citation></ref></ref-list></back></article>